Matters Capital LLC Acquires New Holdings in HCA Healthcare, Inc. $HCA

Key Points

• Matters Capital LLC acquired 4,401 shares of HCA Healthcare worth approximately $1.7 million in the second quarter, while institutional investors collectively own 62.73% of the stock.
• HCA reported quarterly revenue of $20.23 billion and adjusted earnings of $7.59 per share, exceeding analyst estimates; revenue increased 8.7% year over year.
• The company declared a quarterly dividend of $0.78 per share, equal to a $3.12 annualized payout and a 0.7% yield. Analysts maintain a “Moderate Buy” consensus with an average price target of $462.64.

Matters Capital LLC purchased a new stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 4,401 shares of the company's stock, valued at approximately $1,716,000. HCA Healthcare accounts for about 1.2% of Matters Capital LLC's investment portfolio, making the stock its 23rd largest holding.

A number of other institutional investors have also added to or reduced their stakes in HCA. Brighton Jones LLC purchased a new position in shares of HCA Healthcare during the fourth quarter worth about $1,021,000. NewEdge Advisors LLC lifted its position in HCA Healthcare by 11.9% during the first quarter. NewEdge Advisors LLC now owns 3,859 shares of the company's stock valued at $1,334,000 after purchasing an additional 409 shares during the last quarter. Sivia Capital Partners LLC increased its holdings in shares of HCA Healthcare by 5.5% in the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company's stock worth $241,000 after buying an additional 33 shares during the last quarter. Jump Financial LLC purchased a new position in HCA Healthcare in the second quarter worth $2,073,000. Finally, Sei Investments Co. raised its position in HCA Healthcare by 56.3% during the second quarter. Sei Investments Co. now owns 136,589 shares of the company's stock valued at $52,328,000 after purchasing an additional 49,214 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Stock Up 5.6%

Shares of NYSE HCA opened at $429.08 on Friday. The company has a market cap of $92.90 billion, a price-to-earnings ratio of 14.36, a PEG ratio of 1.49 and a beta of 1.10. The firm's fifty day moving average is $397.16 and its 200 day moving average is $444.14. HCA Healthcare, Inc. has a 52 week low of $353.99 and a 52 week high of $556.52.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings results on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $7.56 by $0.03. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The business had revenue of $20.23 billion for the quarter, compared to analyst estimates of $19.76 billion. During the same quarter last year, the firm earned $6.84 EPS. The company's revenue was up 8.7% on a year-over-year basis. Equities research analysts anticipate that HCA Healthcare, Inc. will post 29.47 earnings per share for the current year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be paid a dividend of $0.78 per share. The ex-dividend date of this dividend is Wednesday, September 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.7%. HCA Healthcare's payout ratio is 10.45%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on HCA shares. Royal Bank Of Canada reissued an "outperform" rating and set a $435.00 price objective on shares of HCA Healthcare in a report on Monday, July 27th. Sanford C. Bernstein reiterated a "market perform" rating on shares of HCA Healthcare in a research report on Wednesday, July 15th. Weiss Ratings cut shares of HCA Healthcare from a "buy (b-)" rating to a "hold (c+)" rating in a research note on Tuesday, June 9th. Raymond James Financial set a $528.00 price target on shares of HCA Healthcare in a research note on Tuesday, July 7th. Finally, UBS Group reduced their price objective on HCA Healthcare from $635.00 to $579.00 and set a "buy" rating on the stock in a research note on Monday, July 27th. Fourteen research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $462.64.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source